Craig L. Jensen, MD

Dr. Jensen strives to provide compassionate, up-to-date care care to children with gastrointestinal and nutritional problems. 

Clinical Interests

Dr. Jensen sees patients with a wide array of gastrointestinal, liver and nutritional problems.  He is especially interested in caring for children whose medical problems have had nutritional consequences, including patients with cystic fibrosis.  Dr. Jensen also is the director of a nutrition course that is required for medical students at Baylor College of Medicine. 

Education

,

,

Organizations

,

,

,

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Research interests

Dr. Jensen’s research interests have included investigations of how nutrition of infants affects their utilization of carbohydrates and different types of fat, the effect of different intakes of long-chain polyunsaturated fatty acids during infancy on neurodevelopment and visual function, the effect of orlistat on weight loss in obese adolescents, and currently the effect of glutathione on weight gain, growth and biochemical outcomes in children with cystic fibrosis. 

Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ. A randomized, double-blind, placebo-controlled trial of dietary docosahexaenoic acid (DHA) supplementation in children with autism. Journal of Pediatric Gastroenterology and Nutrition 2014; 58:715-22.

Jensen CL, Voigt RG, Llorente AM, Peters SU, Prager TC, Zou YL, Rozelle JC, Turcich MR, Fraley JK, Anderson RE, Heird WC. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. Journal of Pediatrics 2010;157:900-5.

Jensen CL, Lapillonne A.  Docosahexaenoic acid and lactation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009; 81:175-8. 

Lapillonne A, Jensen CL. Reevaluation of the DHA requirement for the premature infant. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009; 81:143-150. 

Jensen CL. Effects of n-3 fatty acids during pregnancy and lactation. American Journal of Clinical Nutrition 2006;83:1452S-1457S. 

Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. Journal of the American Medical Association (JAMA) 2005;293:2873-83.

Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC.  A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.  Journal of Pediatrics 2001;139:189-96.

Jensen CL, Maude MB, Anderson RE, Heird WC. Effect of docosahexaenoic acid supplementation of lactating women on milk total lipid, and maternal and infant plasma phospholipid fatty acids. American Journal of  Clinical  Nutrition  2000; 71:292S-299S.  

Sauerwald TU, Hachey DL, Jensen CL, Chen H, Anderson RE, Heird WC. Intermediates in endogenous synthesis of C22:6ω3 and C20:4ω6 by term and preterm infants. Pediatric Research 1997; 41:183-7.

Jensen CL, Prager TC, Fraley JK, Anderson RE, Heird WC. Effect of dietary linoleic/α-linolenic acid ratio on growth and visual development of term infants. Journal of  Pediatrics 1997; 131:200-9.